Creating tissues using advanced 3D bioprinting technology
High-throughput Spheroid Bioprinting Technology for Scalable Fabrication of Tissues
This study is exploring a new way to use 3D printing to create tiny clusters of cells that can be shaped into realistic tissue structures, which could help in making better replacements for damaged organs.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Pennsylvania State University, the NIH-funded |
| Lab location | 1 site (University Park, United States) |
| Project ID | NIH-11126620 on NIH RePORTER |
What this research studies
This research focuses on developing a new bioprinting technology that allows for the rapid and precise creation of cellular aggregates, known as spheroids, which can be arranged into complex tissue structures. By overcoming current limitations in spheroid positioning and viability, this approach aims to produce tissues that closely mimic natural organs. The methodology involves high-throughput printing techniques that can work with various sizes of spheroids, enabling the fabrication of scalable tissue constructs for potential medical applications.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that could benefit from tissue regeneration or replacement, such as those with organ damage or degenerative diseases.
Not a fit: Patients with stable conditions that do not require tissue engineering or those who are not candidates for regenerative therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective tissue engineering solutions for regenerative medicine.
How similar studies have performed: Previous research in bioprinting technologies has shown promising results, indicating that this approach could lead to significant advancements in tissue engineering.
Where this research is happening
University Park, United States
- Pennsylvania State University, the — University Park, United States (Active)
Researchers
- Principal investigator: Ozbolat, Ibrahim — Pennsylvania State University, the
- Study coordinator: Ozbolat, Ibrahim
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.